One of the most common questions after a potential STD exposure is: how soon can I get tested? It’s a reasonable question. The answer, unfortunately, is not as simple as most online guides suggest — and getting it wrong in either direction has real consequences.
Testing too late means living with unnecessary anxiety. But testing too early is the more clinically significant error: a negative result during the window period is not a genuine negative. It means the test was done before the infection — if present — had produced enough of a detectable signal. The result looks reassuring. It isn’t.
This article explains what the window period is, why it differs between infections, and what the right timing looks like for each of the STDs in a standard screen. A separate article on When should I get tested for an STD? covers the broader question of when testing is warranted.
What is the window period?
Every STD test works by looking for a specific signal: either the pathogen itself (its genetic material or a protein it produces), or the immune system’s response to it (antibodies). The window period is the time between infection and when that signal becomes detectable.
This gap exists for biological reasons. Some tests look for viral RNA or bacterial DNA — these can appear within days of infection. Others look for antibodies, which the immune system only begins producing after it has recognised and responded to the pathogen — a process that takes weeks. The window period is therefore not a flaw in the tests. It is a function of the biology.
The practical implication is this: a negative result during the window period tells you only that the test could not yet detect infection. It does not tell you that infection is absent. Repeating the test after the window has closed — if the initial test was taken too early — is the correct response to a specific exposure, not false reassurance.
The practical implication is that a test timed incorrectly can give false reassurance. If you are unsure whether you are inside or outside the window for a specific infection, that is the question to put to a doctor before you test.
Two situations, two different clinical problems
Before covering each infection individually, it is worth separating two distinct scenarios that are often conflated.
The first is testing after a specific exposure: a known event, a defined concern. In this situation, the window period is the central question. You need to know which infection you are concerned about, which test detects it, and when that test becomes reliable. Testing too early may require a repeat.
The second is routine periodic testing: regular screening for a man who tests every three to six months, for example. In this situation, window periods are largely irrelevant. If your last potential exposure was weeks or months ago, every infection you might have acquired will have long since declared itself on a standard panel. You are not testing in a window — you are testing well after one.
The rest of this article is primarily relevant to the first scenario. If you are testing routinely after an uneventful period, book an appointment and test.
If you are testing after a specific exposure, read on.
Window periods by infection
HIV
HIV has the most clinically significant window period discussion, partly because the stakes are higher and partly because the guidance has evolved and many patients have outdated information.
The current standard in private clinics in Singapore is the fourth-generation laboratory test, which detects both the p24 antigen (a viral protein that appears early) and HIV antibodies. According to BHIVA/BASHH 2020 guidelines — the current UK standard — a negative result on a fourth-generation laboratory test at 45 days post-exposure is considered conclusive.[1] Testing at four weeks will detect approximately 95% of infections; at 45 days, 99%.[1]
The old guidance suggesting a three-month window applied to third-generation antibody-only tests, which are no longer used for routine screening. Patients who have been told they need to wait three months may be working from outdated information. Point-of-care rapid tests and home self-tests, however, do still have a 90-day window — this is a function of the test format, not the underlying biology.[1]
HIV RNA PCR testing can detect infection from approximately 10–14 days after exposure,[2] but this is not a standard screening tool. This is used for follow up on for HIV patients under treatment and not for screening for HIV.
Key figures: 4th-generation lab test: conclusive at 45 days. Rapid/self-test: 90 days. RNA PCR: detectable from 10–14 days (specialist use only).
If you think you may have been exposed to HIV within the last 72 hours, do not wait for a test result — contact a doctor or attend an emergency department immediately. PEP, not testing, is the priority at that point.
Chlamydia and gonorrhoea
These two bacterial infections are tested using nucleic acid amplification tests (NAAT), which detect the genetic material of the bacteria directly — not the immune response to them. This is why their window periods are short.
For chlamydia, NAAT testing is reliable from approximately one to two weeks after exposure, with most clinical guidance recommending testing at two weeks for dependable results.[3] However, if you are symptomatic – pain passing urine or discharge, you can test as early as 2 – 3 days.
For gonorrhoea, the incubation period is typically 2 to 7 days, and NAAT can detect infection as early as one to two weeks after exposure.[4] Both infections are frequently asymptomatic, which is precisely why testing — rather than waiting for symptoms — is the clinically appropriate response.
Both infections are treatable with antibiotics, and the short window period means that most men concerned about a recent exposure can test reliably within a fortnight.
Key figures: Chlamydia and gonorrhoea: test at 1–2 weeks post-exposure for reliable results unless symptomatic. Both detected by NAAT from urine or swab.
Syphilis
Syphilis is detected by blood serology — meaning the test looks for antibodies produced in response to the bacterium Treponema pallidum. Antibody production takes time, which is why syphilis has a longer window period than the bacterial STDs detected by NAAT.
According to CDC laboratory recommendations published in 2024, the incubation period for primary syphilis is 10 to 90 days, with an average of approximately three weeks.[5] Serologic testing becomes reactive for most patients around two to four weeks after a primary lesion appears, but approximately 20 to 30 percent of patients may still have a non-reactive serology at that point.[6]
The clinical guidance for syphilis is: if a specific exposure occurred less than six weeks before testing, a negative result should be confirmed with a repeat test. For high-risk exposures, repeating at 12 weeks post-exposure provides a more conclusive baseline.[7]
Key figures: Reliable serology from 3–6 weeks. Repeat at 12 weeks after high-risk exposure for a conclusive result.
Hepatitis C
Hepatitis C is most commonly tested by antibody detection, which has a window period of approximately 8 to 11 weeks from exposure to seroconversion, according to CDC surveillance guidance.[8] This is one of the longer windows in a standard panel, and it means that testing immediately after a potential exposure will not produce a reliable antibody result.
HCV RNA testing can detect infection from approximately one to two weeks after exposure,[9] but this is not used as a routine first-line test. For a confirmed exposure with specific concern about hepatitis C, HCV RNA can be used under specialist guidance to detect early infection. For standard screening purposes, antibody testing at or after three months is the practical approach, with a follow-up test at six months confirming a conclusive negative.
Key figures: Antibody test: reliable at 8–11 weeks; conclusive at 6 months. RNA testing: detectable from 1–2 weeks (specialist use).
Hepatitis B
Hepatitis B surface antigen (HBsAg) — the standard initial marker for acute infection — typically becomes detectable around 4 weeks after exposure, but the range is wide: as early as 1 to 2 weeks and as late as 11 to 12 weeks, according to CDC guidance.[10] This variability means that a negative HBsAg test taken shortly after a potential exposure may not be conclusive. For a specific high-risk exposure, a follow-up test at 3 months is prudent. For men who are vaccinated against hepatitis B — as recommended in Singapore — the question of acute infection risk is substantially reduced, but vaccination status should be confirmed and, if incomplete, the series completed.
Key figures: HBsAg typically detectable at 4 weeks (range 1–12 weeks). Negative result shortly after exposure should be repeated at 3 months. Vaccination substantially reduces risk of acute infection.
Herpes (HSV)
Testing for herpes takes the form of blood tests and a swab test. The blood test determines if the infection is chronic ( > 3 months) while a swab test of the lesions determines if there is an acute infection. The significance of this comes because herpes is a lifelong infection and many patients with both chronic and acute infections can present with lesions and not know if they are newly infected or have had the infection for many months.
If symptoms are not present, a positive blood tests shows that there is a chronic infection that has been around for more than 3 months. The implication of this would be that the patient will need to be mindful that there is a chance of symptoms occurring at some point of his/her life.
When symptoms are present — a blister, sore or ulcer in the genital area — swab testing from an active lesion is both sensitive and informative, and can be done within two to three days of the lesion appearing. A positive swab confirms that there is an acute flare, coupled with a positive blood test, doctors are able to determine that this patient has a chronic herpes infection and is experiencing a flare while if the blood test is negative and the swab test positive, it can be said that the patient is a newly diagnosed herpes patient experiencing their first herpes flare. Serology taken during or shortly after a primary episode can also be used, but IgG antibodies may take 12 to 16 weeks to reach reliably detectable levels.[12]
Key figures: Swab from active lesion: within days of lesion appearance. Serology in asymptomatic individuals: not routinely recommended.
Summary: window periods at a glance
These figures apply to laboratory-based testing. Rapid or point-of-care tests have longer windows. Speak to your doctor about which test is being used.
| Infection | Test type | Earliest reliable test | Conclusive negative |
|---|---|---|---|
| HIV | 4th-gen Ag/Ab (lab) | ~18 days (early signal) | 45 days |
| HIV | RNA PCR | 10–14 days | Not used as standard screen |
| HIV | Rapid / self-test (3rd-gen) | — | 90 days |
| Chlamydia | NAAT (urine/swab) | 1–2 weeks | 2 weeks |
| Gonorrhoea | NAAT (urine/swab) | 1–2 weeks | 2 weeks |
| Syphilis | Serology (blood) | 3–6 weeks | 12 weeks after high-risk exposure |
| Hepatitis C | Antibody (blood) | 8–11 weeks | 6 months |
| Hepatitis C | RNA (blood) | 1–2 weeks | Specialist-guided |
| Hepatitis B | Surface antigen (blood) | Typically 4 weeks (range 1–12 weeks) | Repeat at 3 months for high-risk exposure |
| Herpes (HSV) | Swab (lesion present) | 2–3 days (from active lesion) | N/A (symptoms-based) |
If your situation does not map neatly onto this table — because the exposure was unclear, the timing is uncertain, or you have symptoms — a consultation is more useful than self-navigating the framework.
What this means in practice
If you had a specific exposure and are trying to decide when to test, the answer depends on what you are concerned about. For chlamydia and gonorrhoea, a fortnight is usually enough. For HIV, a 4th-generation lab test at 45 days is conclusive. For syphilis and hepatitis, a longer wait or a repeat test is often needed.
Understanding which test is being used matters as much as knowing the window period. A 4th-generation laboratory HIV test and a rapid self-test have different windows for the same infection. When in doubt, confirm with the clinician which test generation is being used and what the corresponding window period is.
Two situations warrant action rather than planning. The first is a potential HIV exposure: if you think you may need HIV post-exposure prophylaxis (PEP), it must be started within 72 hours of the exposure — ideally within 24. This is time-critical. If a clinic cannot see you immediately, attend a hospital emergency department. The second is any symptoms — discharge, pain on urination, sores or ulcers — which should be assessed promptly regardless of where you are in the window period.
For everything else, the window period is not a reason to panic. It is a reason to plan. Test at the right time, with the right test, and the result you receive will be one you can rely on.
A negative result obtained too early is not a reliable negative — and getting the timing right is the part most worth getting right. If you have had a specific exposure and are uncertain about the right timing or which tests to prioritise, speak to a doctor before testing.
- BHIVA/BASHH/BIA. Adult HIV Testing Guidelines 2020. British HIV Association; 2020. bhiva.org.
- HIV i-Base. What is the window period for an HIV test? i-base.info. Updated 2023.
- Centers for Disease Control and Prevention. Chlamydial Infections. In: Sexually Transmitted Infections Treatment Guidelines, 2021. MMWR Recomm Rep. 2021;70(4).
- California Department of Public Health. Antibiotic-Resistant Gonorrhea (ARGC) Quicksheet. April 2025. cdph.ca.gov.
- Centers for Disease Control and Prevention. CDC Laboratory Recommendations for Syphilis Testing, United States, 2024. MMWR Recomm Rep. 2024;73(1):1–32. PMC10849099.
- Syphilis — Screening and Diagnostic Testing. UpToDate.
- Communicable Diseases Agency, Singapore. Syphilis. cda.gov.sg/professionals/diseases/syphilis.
- Centers for Disease Control and Prevention. Additional Information and Resources: Viral Hepatitis Surveillance. cdc.gov.
- Centers for Disease Control and Prevention. Testing and Clinical Management of Health Care Personnel Potentially Exposed to Hepatitis C Virus. MMWR Recomm Rep. 2020;69(6):1–17.
- Centers for Disease Control and Prevention. Epidemiology and Prevention of Vaccine-Preventable Diseases (Pink Book), Chapter 10: Hepatitis B. cdc.gov.
- US Preventive Services Task Force. Serologic Screening for Genital Herpes Infection: Reaffirmation Recommendation Statement. JAMA. 2023;329(6):502–507.
- STD Center NY. STD Testing Facts from Earliest Testing Time to Definitive. stdcenterny.com.